Tissue distribution of (lipocurc™) liposomal curcumin and tetrahydrocurcumin following two- and eight-hour infusions in beagle dogs

Anticancer Research

Volumn 32, Issue 10, 2012, Pages 4359-4364

  Matabudul, Dharmendr ^a   Pucaj, Kresimir ^a   Bolger, Gordon ^a   Vcelar, Brigitta ^b   Majeed, Muhammed ^c   Helson, Lawrence ^d  

^a Nucro Technics   (Canada)

^b Polymun Scientific   (Austria)

^c Sabinsa Coporation   (United States)

^d SignPath Pharma Inc   (United States)

Author keywords

Curcumin; Medium chain dehydrogenase reductase; Tetrahydrocurcumin; Tissue distribution; Tissue partition co efficient

Indexed keywords

CURCUMIN; DRUG METABOLITE; LIPOCURC; LIPOSOMAL CURCUMIN; TETRAHYDROCURCUMIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLADDER; DOG; DRUG DISTRIBUTION; DRUG METABOLISM; DRUG TISSUE LEVEL; FEMALE; KIDNEY; LIVER; LUNG; MALE; NONHUMAN; PANCREAS; PRIORITY JOURNAL; SPLEEN;

ANIMALS; CURCUMIN; DOGS; FEMALE; INFUSIONS, INTRAVENOUS; LIPOSOMES; MALE; PHOSPHORIC ACIDS; TISSUE DISTRIBUTION;

EID: 84867821358     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Hassaninasab A, Hashimoto Y, Tomita-Yokotani K and Kobayashi M: Discovery of the curcumin metabolic pathway involving a unique enzyme in an intestinal microorganism. Proc Natl Acad Sci USA 108(16): 6615-6620, 2011.
2. Knoll M and Pleiss J: The medium-chain dehydrogenase/ reductase engineering database: a systematic analysis of a diverse protein family to understand sequence-structure-function relationship. Protein Sci 17(10): 1689-1697, 2008.
3. Clinical Trials. Gov (curcumin), 2012.
4. Helson L: Intravenous infusion of curcumin and a calcium channel blocker. Patent application number: 20110117186, 2011
5. Helson L, Bolger G, Majeed M et al: Infusion Pharmacokinetics of Lipocurc™ and its Metabolite Tetrahydrocurcumin in Beagle Dogs. Anticancer Res (32)10: 4365-4370, 2012
6. Nucro-Technics Bioanalytical Report: Project # 253395, 2012.
7. Tsai Y-M, Chien C-F, Lin L-C and Tsai T-H: Curcumin and its nano-formulation: The kinetics of tissue distribution and bloodbrain barrier penetration. Int J Pharmaceutics 416: 331-338, 2011.
8. Suresh D and Srinivasan K: Tissue distribution and elimination of capsaicin, piperine and curcumin following oral intake in rats. Indian. J Med Res 131: 682-691, 2010.
9. Tang X-Q, Bi H, Feng J-Q and Cao J-G: Effect of curcumin on multidrug resistance in resistant human gastric carcinoma cell line SGC7901/VCR. Acta Pharmacologica Sinica 8: 1009-1016, 2005. (Pubitemid 41153224)
10. Shukla S, Zaher HM, Harta A, Bauer B, Ware JA and Suresh VA: Curcumin inhibits the activity of ABCG2/BCRP1, a multidrug resistance-linked ABC drug transporter in mice. Pharm Res 26: 480-487, 2009.